Related Experiment Videos
Metallothioneins and microelements in brain tumours
Bolesław Floriańczyk1, Robert Kaczmarczyk, Jacek Osuchowski
1Department of Biochemistry and Molecular Biology, Medical University of Lublin, Lublin, Poland.
Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina
|August 19, 2004
Summary
Metallothioneins, crucial for metal homeostasis and cellular protection, showed slightly elevated levels in malignant gliomas compared to benign astrocytomas. Copper levels did not significantly differ between these brain tumor types.
Area of Science:
- Biochemistry
- Oncology
- Neuroscience
Background:
- Metallothioneins (MTs) are vital proteins involved in metal ion homeostasis (zinc, copper), regulation of zinc-dependent enzymes, and cellular defense mechanisms.
- These proteins protect cells against oxidative stress, radiation, and toxic agents, including those used in cancer chemotherapy.
- Dysregulation of MTs is implicated in various pathologies, including cancer.
Purpose of the Study:
- To investigate the levels of metallothioneins, zinc, and copper in benign (astrocytoma G-2) and malignant (glioblastoma multiforme GM-4) brain gliomas.
- To determine the potential role of MTs and associated metal ions in the progression of gliomas.
Main Methods:
- Quantification of metallothionein levels using a cadmium-hemoglobin affinity assay with cadmium isotope (109Cd).
- Determination of zinc and copper concentrations via atomic absorption spectrophotometry.
- Comparative analysis of protein and metal ion levels between benign and malignant glioma patient groups.
Main Results:
- Slightly higher levels of metallothioneins were observed in the malignant glioma group (glioblastoma multiforme) compared to the benign glioma group (astrocytoma).
- A statistically significant difference in MT levels was noted between the malignant and benign groups.
- No significant difference in copper levels was found between the malignant and benign glioma groups.
Conclusions:
- Metallothionein levels may be altered during glioma progression, with a tendency towards higher expression in more aggressive tumors.
- While MT levels differ, copper homeostasis appears less affected in the studied benign versus malignant glioma samples.
- Further research is warranted to elucidate the precise role of metallothioneins in brain tumor development and their potential as diagnostic or therapeutic targets.